F LICKER may be defined as the visual sensation produced by intermittent flashes of light. At a certain rate of such flashes a sensation of continuous brightness is experienced and this rate is called the critical fusion frequency (C. F. F.) or flicker fusion threshold (F. F. T.). These values can be obtained with a flicker photometer. Duke-Elder' has established flicker photometry as a sound method of obtaining quantitative values for this basic physiologic function.
The method of flicker photometry had its beginning in the rotating tops first mentioned by \Iusischenbrock.2 More recently, flicker fusion has usually been studied by sectored disks which rotate between a constant light source and the subject to be tested. The speed of rotation of such disks can be recorded and the number of flickers per second at which the subject sees fusion of the flickering light can be obtained. Various investigators have shown that fatigue3'4 hypoxia,5 advancing age6 and lower relative intelligence' cause a decrease in the flicker fusion threshold. It has been generally found that similar testing conditions are necessary to achieve reproducible results on successive days.
Krasno and Ivy8 have recently reported the effect of nitroglycerin on the flicker fusion threshold. Using their less complicated instrument, they have studied 421 subjects by a procedure which will be described later. They postulate that after sublingual nitroglycerin administration patients having spasm of their retinal arterioles will show a significant increase in their flicker fusion threshold over their initial threshold, while normal subjects not having such spasm will show a decrease in their threshold under similar experimental conditions. This hypothesis is based on the premise that nitroglycerin can relieve vasospasm of the retinal arterioles resulting in a more adequate blood and oxygen supply to the retina, thus increasing visual acuity. On the other hand, if vasospasm is not present, nitroglycerin will cause passive hyperemia of the retina, decreasing visual acuity. They have reported that patients with hypertension and arteriosclerosis, or hypertension alone, and patients recovering from coronary artery occlusion and myocardial infarction have an increase in their flicker fusion threshold following nitroglycerin administration. The authors further suggest that such a method of observing flicker fusion change may show those persons who are predisposed to hypertension and/or myocardial infarction by bringing to light vasospasm not otherwise recognized. In order to further investigate this approach to vascular disease, a group of normal subjects and patients with hypertension and allied states have been tested in the manner proposed by these authors.
METHOD
As our investigation progressed, we incorl)oratecl certain modifications into our procedure which were suggested by Dr. Krasno Krasno and Ivy found that these subjects would give a normal test after receiving papaverine, 60 mg. three times daily for three days.
The patient's response to nitroglycerin was obtained by taking the difference between the maximum postnitroglycerin flicker fusion threshold and the initial flicker fusion threshold. The original investigators considered a change of plus or minus 60 flashes or greater as significant. Thus, a decrease of 60 or more flickers a minute in the patient's response was designated a "normal test," while an increase of 60 or more per minute was designated an "abnormal test." Anything less than plus or minus 60 flashes was designated a "no change response," after which a second tablet of nitroglycerin was given.
This testing procedure was modified by Krasno and Ivy in order to achieve more reproducible flicker fusion threshold values. In the original manuscript the investigator was instructed to turn the control knob slowly to reduce the flashes of light per minute. The authors now state that the control knob should first be turned slowly at an optimum speed and then at a creeping* rate as the subject's suspected threshold is approached. By so doing it is contended that the subject is given the best opportunity to give his maximum response to a flickering light. Another recommendation has been made: instead of obtaining the flicker fusion theshold readings every two minutes for six minutes after giving nitroglycerin, two minute intervals are to be allowed between each of three series of postnitroglycerin determinations. The importance of these changes will be discussed later. Throughout our investigation extreme care was exerted to study subjects in whom were found only those factors which could be tested by the nitroglycerin-flicker test. If subjects were found to have physical or mental factors known to affect the test adversely, they were excluded from the study. Every effort was made to assure the subject's complete mental relaxation and physical comfort before the test was started.
RESULTS
As the changes in technic became known to us, it was necessary to divide our investigation and data into two separate and distinct parts. The first part represents that phase of the investigation during which the control knob was turned at a constant rate of speed, and the original two, four and six minute observation periods were used in the postnitroglycerin phase of the test. The flicker fusion threshold values were difficult to determine because three similar readings were not easily obtained. Therefore, it was decided to use the arithmetic mean of ten determinations obtained before nitroglycerin administration as the initial flicker fusion threshold. After nitroglycerin was administered, four measurements were taken during each of the three two minute periods. The arithmetic mean of the four measurements was used to represent the subject's postnitroglycerin flicker fusion threshold at the two, four and six minute intervals.
Thirty normal human controls showing no evidence of vascular disease were studied. Their age ranged from 18 to 36 years, averaging 26.4 years. Tw!enty-five of this group gave a normal response and 5 gave an abnormal response. The latter 5 were not given papav-erine or examined for possible anemia, since the technic of testing was changed before this was done. Not included in the control group of 30 subjects mentioned above were 4 additional patients whose initial response to the test was abnormal. These were found to have normal erythrocyte counts and hemoglobin concentrations. They were given papaverine orally, 60 mg. three times daily for three days, after which they were retested. All We again made every effort to study only those subjects whose slit-lamp microscope, using a technic previously described by Lee 2408  2520  2565  2415  2175  2215  2230  2160  2175  2620  2650  2520  1555  1955  2200  2195  1965  2330  2530  2275  2375  1920  2355  1860  1955   2450   60  65  64  21  62  41  45  49  42  53  63  55  70  60  64  60  44  52  39  57  65  71  55  68  59  58  59  64  68  70  66  67  45   35,3 also showed an abnorn responded in the mannE Lueth and Hanks"4 observed the nail fold capillaries of 32 hypertensive subjects who were given 0.2 mg. of nitroglycerin sublingually. They reported that in the majority of these cases there was "an increased rate of flow through the capillaries of the skin several minutes after the drug was given, unaccom--panied by any change in size of either the arteriolar or venous limb." On the other hand, they state: "In three cases a decreased rate of flow followed taking the drug. In only a few cases (4 patients) did complete blanching, i.e., disappearance of the vessel, occur." This report continued as follows: "Another interesting observation was the simultaneous reaction of pairs of capillary loops. In some fields these paired vessels could be easily detected by their synchronous acceleration, slowing and cessation of blood flow in contrast to the other capillaries that did not present identical variations. Some of these paired vessels could be traced to a single common arteriole, a more
